Many patients with severe asthma are treated with monoclonal antibodies which target the asthma inflammatory pathways, such as those targeting IgE, Interleukin (IL)-5 and its receptor, and the IL-4 receptor α subunit. The gene discussed is IGHE; the disease is asthma.